(PharmaNewsWire.Com, January 03, 2017 ) Embolic Protection Devices Market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years and discussion of the key vendors effective in this market. To calculate the market size, the report considers the revenue generated from the sales of Embolic Protection Devices globally.
The Embolic Protection Devices Market report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry.
Following Companies Are Key Players of the Embolic Protection Devices Market:
Abbott Laboratories Boston Scientific Cardinal Health Medtronic
Other Prominent Vendors of Embolic Protection Devices Market Are:
Abiomed AdvanSource Biomaterials AGA Medical Allium Medical Solutions AngioDynamics Angioslide
“Integrated technologies by small companies for market penetration is a key trend for this market. Small companies develop advanced technologies to enter the market. Until date, only a few products are in their development stage or have received regulatory approval only in one region. These products are highly advanced and specific to the preference of physicians. Post approval, these advanced devices can pose a threat to large companies such as Medtronic and Boston Scientific.”
According to the Embolic Protection Devices Market report, incidence of cardiac diseases and adoption of PCI is a key driver for this market. The incidence of cardiac diseases is on the rise worldwide. In 2015, the CDC estimated that these diseases caused about 610,000 deaths in the US. The organization also estimates that coronary heart disease was the most common cardiac disease, causing 375,000 deaths in the US annually. To treat these diseases, physicians diagnose and may recommend surgeries based on their stage.
Report also presents Geographical Segmentation analysis of Embolic Protection Devices Market of Americas, APAC, EMEA region.
Further, the Embolic Protection Devices Market report states that high cost of stenting is a challenge to market growth. The demand for and use of embolic protection devices is low in many countries due to the high cost of stenting. The overall cost associated with stenting varies among hospitals based on the stent procedure, patient care, and hospital stay. The overall cost associated with stenting can be $12,000-$38,000, with the average price of the stents being $2,000-$4,500. The price of stents may further increase depending on the type of advanced technology used. The stenting procedure costs $7,000-$28,000.
Key questions answered in Embolic Protection Devices market report:
What will the Embolic Protection Devices market size be in 2020 and what will the growth rate be? What are the key market trends? What is driving Embolic Protection Devices market? What are the challenges to Embolic Protection Devices market growth? Who are the key vendors in Embolic Protection Devices market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
Market Reports World is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: